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Sdischarge. Retroperitoneal bleeding, pseudoaneurysm, arteriovenosus ﬁstula and
hematoma were considered the composite endpoint of major vascular complications
(MVC). Secondary endpoints were: death, stroke, myocardial infarction, amputation
and target lesion revascularization (TLR).
Results: The study cohort had average age of 79 (range 70- 95) years compared to
60.9 in the control group (range 38- 69). Study group were more likely to be female,
but less likely to be current smokers, diabetic and dialysis reliant (p < 0.001). There
were no differences between groups in VCD deployment and critical limb ischemia.
The mean time to ambulation in the elderly and control group were 3.6 hours (1.2)
and 3.4 hours (1.3) respectively (p¼ 0.8). In 24 hours as well as in 30 days follow up
there were no signiﬁcant differences in the primary and secondary endpoints between
groups. Current smoking status (OR¼2.35, 95% CI: 0.485- 11.46) in the octogenar-
ians, whereas female sex (OR¼ 1.75, 95% CI: 0.389- 7.86) and hypercholesterolemia
(OR¼ 6.739, 95% CI: 0.294- 154.4) in controls were found to be independent
predictors of MVC at 30 days.
Conclusions: The same day discharge after ER on lower extremities is safe and
feasible in the elderly.
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Background: The atherosclerosis plaques have different morphology from soft
neointimal plaques to hard calciﬁed lesions. Therefore, we sought to evaluate the
efﬁcacy of percutaneous balloon angioplasty (PTA) versus atherectomy (AT) endo-
vascular revascularization which type was attuned by operator.
Methods: Between 2008 and 2013 a total of 419 endovascular revascularizations were
performed on arteries of lower extremities. In this registry we include patients with
claudication as well as with critical limb ischemia (CLI). The endpoints were
considered as target lesion revascularization (TLR), amputation, major adverse
cardiovascular event (MACE) and bailout stenting (BS). MACE was deﬁned as death,
myocardial infarction and stroke. The type of atherectomy (excisional- soft plaque,
orbital- calciﬁed plaque, with active aspiration- with a thrombus) was left to the
operator's discretion
Results: The PTA was performed on 215 patients, whereas AT was used in 204 cases
(Silver Hawk TM, EV3- MN, USA -125; CSI360 MN, USA- 66 Pathway Medical
Technologies- 13). The mean follow up time was 500 (454) days. There were no
signiﬁcant differences in baseline characteristics between groups with the exception of
increased coronary artery disease, dialysis and CLI for PTA group. There were
signiﬁcant differences in TVR (PTA: 32% vs. AT: 21%; p¼0.01), death (PTA8% vs.
AT: 2%; p¼0.009) and BS (PTA:9% vs. AT:1% p<0.001). Kaplan- Mayer analysis
showed no signiﬁcant differences between groups in time to TLR, amputation, death.
After adjustment this was sustained.
Conclusions: In this observational analysis, atherectomy endovascular revasculari-
zation offered better long term outcomes than balloon angioplasty.
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Background: Primary Patency (PP) in trials assessing Superﬁcial Femoral Artery
(SFA) stenting is deﬁned as a combination of vessel patency assessed by Duplex
ultrasound (DUS) at 12 month visit and freedom from revascularization of the index
vessel through 12 month follow-up. Patients are thus more likely to lose PP during the
mandated DUS assessment. Moreover, DUS is performed within a pre-speciﬁed
window which exceeds 12 months, thus the time frame for analyzing patency via DUS
exceeds the time frame by which revascularization is captured. There are no guidelines
as to the correct method for presenting these analysis in reports from clinical trials. We
aimed to analyze the implications of applying different methods in assessing freedom
from loss of PP in studies assessing stenting for SFA disease.
Methods: We simulated a dataset of patients and outcomes based on existing
available results from SFA stenting trials. Six different approaches to Kaplan Meier
(KM) analyses were applied based on entry criteria into and time frame of the KM
model.
Results: Six KM estimates of freedom from loss of PP were generated for each of the
10,000 simulation sets. The six different methods averaged from 67.9% to 81.8%.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Survival analyses of freedom from loss of PP vary substantially
according to the methods employed. These may lead to misrepresentation of results
from clinical trials. The development of a uniﬁed approach is advocated.
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Background: Intermittent claudication affects 2.5% of women and 5% of men over
the age of 60. Advanced age, diabetes, and renal insufﬁciency predispose patients to
intra-arterial calcium which is a predictor of poor endovascular treatment success.
Methods of treating peripheral arterial disease (PAD) have evolved and now include
minimally-invasive endovascular procedures, utilizing orbital atherectomy (OA)
which can modify calciﬁc plaque both above and below-the-knee.
Methods: Three consecutive CONFIRM patient registries were conducted prospec-
tively and enrolled patients on an "all comers" basis to evaluate the use of orbital
atherectomy in peripheral lesions of the lower extremities. Analysis of all 3135
patients enrolled in the CONFIRM I-III registries revealed 1698 patients with clau-
dication (Rutherford Class 1-3) and documented lesion morphology. We analyzed the
CONFIRM series to compare procedural complications after OA treatment of lesions
with moderate/severe calcium versus lesions without moderate/severe calcium in
claudicant patients.
Results: Eighty-two percent of claudicants treated with OA had moderate/severely
calciﬁed lesions. There was no signiﬁcant difference in the percentage of perforations
(0.6% vs 0%), slow ﬂow (2.9% vs 2.6%), closure (1.4% vs 2.3%), spasm (3.8% vs
6.3%), embolism (1.7% vs 2.6%), or thrombus (1.1% vs 1.3%), in claudicants with
moderate/severely calciﬁed lesions vs without moderate/severely calciﬁed lesions,
respectively. Claudicants with moderate/severe calcium had fewer dissections than
those without moderate/severely calciﬁed lesions (10.9% vs 16.2%, p¼0.004).
Conclusions: The majority of the claudicant patients in this study had lesions with
moderate to severe calciﬁcation, yet the occurrence of adverse events was low after
treatment with orbital atherectomy. Orbital atherectomy is a safe tool for restoring
blood ﬂow in the lower extremities of claudicant patients regardless of arterial calcium
burden.
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Background: Prosthetic aortic grafts remain problematic despite enhancements in
biomaterials and production prosthetics, improved surgical techniques, and a better
understanding of the pathogenesis of graft infections. Previously, we investigated
a locally developed technique of bonding aortic grafts with 3 antimicrobials to prevent
early (within 2 weeks) direct perioperative bacterial contamination related to aortic
graft operations. In the current phase, we attempted to determine whether the
concentrations of the antimicrobials bonded to the graft are sufﬁcient to prevent
postoperative aortic graft infections for a longer period (8 weeks).
Methods: Nine Sinclair miniature pigs received a 6-mm vascular Dacron graft in the
infrarenal portion of the abdominal aorta. Six pigs received grafts chemically bonded
with 60-mg/mL solutions of rifampin, minocycline, and chlorhexidine; 3 pigs received
unbonded grafts. Before implantation, the 6 bonded grafts and 2 of the unbonded
grafts were immersed for 15 minutes in a 2-mL bacterial solution containing 1 to
2107 colony-forming units (CFUs)/mL of Staphylococcus aureus (ATCC 29213);
the 3rd unbonded graft served as a control. The pigs were observed for 8 weeks after
graft implantation; then the pigs were sacriﬁced, and the grafts were excised. Beforeacts/POSTER/Endovascular Intervention B165
TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM www.jacctctabstracts2013.com
P
O
S
T
E
R
Simplantation and 8 weeks afterward, the concentrations of the 3 antimicrobials were
measured by high-performance liquid chromatography (HPLC).
Results: The 2 pigs that received unbonded grafts plus bacteria had to be
sacriﬁced during the ﬁrst 2 postoperative weeks because of severe infection and
septicemia; both pigs had high bacterial counts (6.25106 and 1.38107 CFU/graft).
S. aureus–treated bonded grafts showed no bacterial growth on explantation. The
control (unbonded and untreated) graft showed bacterial growth (1.8103 and
7.27103 CFU/graft) that presumably reﬂected direct accidental perioperative
bacterial contamination; S. cohnii ssp urealyticus, but not S. aureus, was isolated.
The histopathologic and clinical data conﬁrmed the microbiologic ﬁndings. Only
one pig that received a bonded graft showed histopathologic evidence of a healed
perigraft abscess. Analysis of antimicrobial concentrations showed that the initial
dosage was sufﬁcient to prevent any bacterial infection during the 8-week post-
operative period.
Conclusions: Our results suggest that bonding aortic grafts with this combina-
tion of 3 antimicrobials prevented perioperative aortic graft infection for at least
8 weeks in an animal model. The concentration of these chemicals was
sufﬁcient to prevent or eradicate any infections. Further studies are needed to explore
the ability of this novel graft to combat one of the most feared complications in
vascular surgery.
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Background: The success rate of endovascular therapy (EVT) for long chronic total
occlusion (CTO) of femoropopliteal arteries has improved because of devices
development and the introduction of the echo or IVUS guided EVT. But now this is
still challenging. In the diagnosis of peripheral artery disease, duplex ultrasonography
is noninvasive, simple and usefulness, but it was impossible to assess the lesion
morphology. Elastography is an ultrasonographic method that has been examined as
a diagnostic tool for breast lesions. We applied this method to hardness measurement
of CTO lesions by our original method. Our aim was to investigate the usefulness of
the ultrasonography (US) "vascular elastography (VE)" in EVT for long CTO lesions
of SFA.
Methods: In 1274 consecutive cases which underwent EVT between April 2010 and
May 2013, we focused on 57 cases of EVT for long CTO of femoropopliteal
arteries, which CTO length was more than 150mm. We assessed the CTO lesions by
duplex US and "VE" about lesion hardness with our original methods before
procedure. US was performed with 8 MHz linear transducer (Aprio XG/500,
TOSHIBA, Japan), and off-line analysis of "VE" was performed with elasto-Q
(TOSHIBA, Japan). We originally categorized into ﬁve types by original VE score.
The ratio of hard appearance portion (VE score 0-1) to CTO (H/T ratio) was evaluated.
Comparing investigation about procedure results was performed between hard group
(H group: hard portion>20%) and non-hard group (NH group: hard portion<20%). In
EVT, guide wire was penetrated with US guided from body surface without
ﬂuoroscopy.
Results: We could assess elastogram of target CTO lesions in all cases (H group: 27
cases, S group: 30 cases). No signiﬁcant difference was detected in CTO lesion
length (H: 28.96.8mm, S: 26.64.7mm). Hard portions were detected in CTO
lesions (H: 10.26.9mm, H/T ratio 32.515.8% vs. S: 1.81.8mm, H/T ratio
7.36.6%; p<0.001). Operation time in H group was longer than S group
(H: 248.0115.1min vs. S: 142.942.1min; p¼0.01). Success rate was H: 92.6% vs.
S: 100%. No signiﬁcant difference was detected in case of retrograde approach
from popliteal artery (H: 29.6%, S: 10.0%). Retrograde approach was needed in only
17 cases which distal site of CTO was VE score 0 to 2 (VE score 0-2: 29.8% vs. 3-4:
0%; p<0.01).Cases in S group could be penetrated with hydrocoat soft guidewire
(12.1% vs. 65.2%; p<0.001). In 11 cases, CTO site was all soft appearance as VE
score 3 to 4. A hydrophilic soft guide wire could pass the lesion easily. Therefore we
successfully performed thrombectomy and distal protection preventing for distal
embolism.
Conclusions: "Vascular Elastography" might be able to predict the difﬁculty of EVT,
useful when we decide strategies and selections of device because we could assess the
vascular morphology noninvasively before procedure. VE could detect the hard pla-
que which difﬁcultly penetrated without calciﬁcation.B166 JACC Vol 62/18/Suppl B j October 27–NTCT-552
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Background: In endovascular therapy (EVT) for superﬁcial femoral artery
(SFA), nitinol selfexpanding stent has been useful compared to only balloon
angioplasty. However strategy for in-stent restenosis (ISR) after SFA stenting was
unclear. Nitinol selfexpanding drug-eluting stent (DES) for SFA has approved in our
country. The primary patency of DES was higher than bare-metal stent (BMS). Our
aim was to investigate clinical outcomes after endovascular therapy (EVT) for BMS-
ISR in SFA.
Methods: In 710 consecutive cases which underwent EVT for SFA between April
2007 and August 2012, we analyzed 68 consecutive cases (74 limbs) which underwent
secondary EVT for SFA lesions of BMS-ISR. In secondary EVT, strategy was only
balloon angioplasty (A group: 24 limbs, 37.5%), nitinol selfexpanding bare metal
stenting (BMS group: 26 limbs, 40.6%) or nitinol selfexpanding pclitaxel-eluting
stenting (Zilver PTX) (DES group: 24 limbs, 21.9%). Either angiography (diameter
stenosis>50%) or duplex ultrasoundgraphy (peak systolic velocity ratio >2.5) were
used at six months follow up to deﬁne restenosis.
Results: Mean age of patient was 67.69.6 years old; diabetic patient was 35 cases
(51.5%). 21 limbs (28.4%) were over Rutherford category 4. In primary EVT,
S.M.A.R.T Control stent or Zilver stent were deployed (mean diameter: 6.60.7mm,
total length 135.893.8mm). In secondary EVT, cases of focal stenosis were 16 limbs
(21.6%), diffuse stenosis were 34 limbs (46.0%), stent fracture were 3 limbs (4.1%)
and 24 limbs (32.4%) were total occluded with thrombus. After secondary EVT,
restenosis rate in DES group was the lowest (DES group: 0 limb vs. A group: 6 limbs,
25.0% vs. BMS group: 5limbs, 19.2%; p<0.01).
Conclusions: In EVT for in-stent restenosis of SFA, nitinol selfexpanding paclitaxel-
eluting stenting might be useful.
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Background: The "Tack-It", a novel metallic 6mm spot-scaffolding technology
was designed to seal local vascular dissections and decrease the risk of vascular
injury. This is achieved through a lower outward radial force and reduction in the
material surface in contact with the vessel compared to the current standard peripheral
stents.
Methods: Superﬁcial femoral arteries of 10 Yucatan swine were randomized to the
implantation of either self-expanding Tacks (n¼4 tacks 6mm each per 40mm segment;
10 arteries) or a self-expanding nitinol stent (40mm Cordis SMART stent; n¼10).
Following implantation, both groups were post-dilated at a 1.1:1.0 balloon to artery
ratio. After 28 days, the target arterial segments were harvested for histological
analysis.
Results: At baseline, angiography demonstrated similar reference vessel diameter
(Tack, 3.810.18mm vs. stent, 4.010.32mm, p¼NS). At 28 days, the minimal
lumen diameter analysis indicated a higher neointimal proliferation in the stent group
(2.600.91mm) compared to the Tack (3.450.28mm) leading to a higher percent
diameter of stenosis (stent 41.517.7% vs. Tack 15.03.2%, p<0.05). The histo-
logical analysis supported the angiographic data. The injury score demonstrated
a higher level of injury caused by the stent deployment (0.440.24) compared to the
Tack (0.120.07, p<0.0001) producing less neointimal proliferation (Neointimal
thickness; stent 0.590.26mm vs. Tack .0.140.034mm; p<0.0001).
Conclusions: In femoral arteries of normal Yucatan swine, this novel peripheral
vascular spot-scaffolding technology maintains lumen patency in the targeted segment
length with less foreign material and lower vascular injury and neointimal prolifera-
tion when compared to standard self-expanding nitinol stents.ovember 1, 2013 j TCT Abstracts/POSTER/Endovascular Intervention
